Login / Signup

Mean lifetime survival estimates following solid organ transplantation in the US and UK.

Christopher N GrahamCrystal WatsonArie BarlevMatthew D StevensonVikas R Dharnidharka
Published in: Journal of medical economics (2022)
Our study estimates reflect real-world survival following SOTs and demonstrate the importance of including long-term hazards in survival estimations. These lifetime survival estimates can be used by decision-makers in situations where means are preferred over medians (e.g. population projections, budgetary estimates, and cost-effectiveness models) and can thus offer a meaningful alternative to the estimates used and accepted in current practice.
Keyphrases
  • free survival
  • healthcare
  • mesenchymal stem cells
  • cross sectional
  • bone marrow
  • cell therapy